Clinical Trials Browser

Phase 2 × Squamous Cell Carcinoma of Head and Neck × Pharmacogenomic Testing × Clear all

NCT01192815 2020-05-12

Erlotinib Hydrochloride and Radiation Therapy in Stage III-IV Squamous Cell Cancer of the Head and Neck

Phase 2 Terminated

2 enrolled 8 charts

Squamous Cell Carcinoma of Head and Neck